Biote Corp. (BTMD) Earnings Call Analysis
NASDAQ · Healthcare · Medical Care Facilities
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Biote (BTMD) Q1 2026: Recall Drives $1.7M Revenue Hit, Sales Force Expansion Sets Up H2 Rebound
May 07, 2026
-
BioT (BTMD) Q4 2025: Sales Force Expands 33% as Clinic Attrition Stabilizes, Setting Stage for H2 Recovery
March 12, 2026
-
BioTE (BTMD) Q3 2025: Procedure Revenue Down 10.4% as Sales Force Transition Delays Growth Rebound
November 06, 2025
-
BIOTE (BTMD) Q1 2025: Dietary Supplement Revenue Jumps 26% as Sales Force Realignment Targets Clinic Growth
July 04, 2025
-
BioT (BTMD) Q3 2024: Software Rollout Triggers 2.5 Point Headwind, Margin Expansion Holds
November 12, 2024
-
BioT (BTMD) Q2 2024: Procedure Revenue Climbs 7.8% as BioTRx Platform Expansion Accelerates Clinic Growth
August 08, 2024
-
BTMD Q1 2024: 6.6% Procedure Growth Anchored in Existing Clinics as Internal Production Ramps
May 07, 2024
-
BioT (BTMD) Q4 2023: BioTRx Launch and 403bp Margin Expansion Signal Competitive Reset
March 12, 2024